Contact Us
Careers
Team
Leadership
Board of Directors
Advisors
Neurotology
Technology
Pipeline
News
Sound Pharmaceuticals and the University of Florida begin enrollment on a Phase II study with SPI-1005 to prevent and treat noise induced hearing loss
By
Sound Pharma
December 5, 2012
June 20th, 2016
Uncategorized
No Comments
– 2012-12-05_ClinicalTrialStart
Search
Archives
Select Year
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
Share
Tweet
Share
Pin
Team
Leadership
Board of Directors
Advisors
Neurotology
Technology
Pipeline
News
Contact Us
Careers